X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-us-square-off-billion-dollar-hiv-drug-patent-trial-2023-05-02/
https://www.fiercepharma.com/pharma/gilead-caused-injuries-while-holding-taf-based-products-lawsuit-alleges
https://www.prnewswire.com/news-releases/hagens-berman-sobol-shapiro-llp-hilliard--shadowen-llp-and-durie-tangri-llp-announce-a-class-action-involving-antiretroviral-drugs-301710696.html
https://endpts.com/federal-claims-court-rules-in-favor-of-gilead-in-cdc-truvada-patent-case/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-hiv-drug-under-pepfar/articleshow/83979412.cms
https://www.fiercepharma.com/pharma/gilead-s-descovy-not-worth-higher-price-over-forthcoming-truvada-generics-study
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-descovy-208215-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-1578411210.pdf
https://www.fiercepharma.com/pharma/gilead-seeking-patent-extension-hiv-meds-runs-into-pushback-from-patient-advocates
https://www.fiercepharma.com/marketing/gilead-s-converting-truvada-prep-users-to-descovy-faster-than-expected-analyst
https://health.economictimes.indiatimes.com/news/industry/laurus-labs-gets-usfda-nod-for-hiv-drug/67821291
https://www.reuters.com/article/us-indonesia-health-aids/indonesia-seeks-to-reassure-hiv-patients-over-drug-supplies-idUSKCN1P704I?feedType=RSS&feedName=healthNews
https://www.medpagetoday.com/meetingcoverage/idweek/75657
https://www.biospace.com/article/is-gilead-poised-for-a-comeback-/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-fixes-prices-of-22-drug-formulations/articleshow/64575442.cms
http://ir.contravir.com/news-releases/news-release-details/contravir-pharmaceuticals-announces-txltm-has-been-granted
http://www.fiercebiotech.com/biotech/geovax-draws-a-bead-hep-b-therapeutic-vaccine-deal
http://seekingalpha.com/article/4033080-glaxo-gilead-hiv-battle-epic
http://twofourinsight.com/indian-generic-manufacturer-cipla-targeting-us-hiv-market/
http://www.pharma-excipients.ch/2016/03/21/a-tunable-biodegradable-thin-film-polymer-device-as-a-long-acting-implant-delivering-tenofovir-alafenamide-fumarate-for-hiv-pre-exposure-prophylaxis/
http://cphi-online.com/new-drugs-from-abbvie-gilead-intercept-and-merck-news038959.html
http://www.biospace.com/News/gilead-faces-lawsuits-over-aids-drug-patents/406896/source=TopBreaking
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-ready-to-launch-low-dose-hiv-drug-efavirenz/articleshow/49979486.cms
http://www.pmlive.com/pharma_news/j_and_j_buys_firm_seeking_hepatitis_b_cure_858801
http://www.fiercebiotech.com/story/gilead-takes-125m-fda-shortcut-its-latest-hiv-combo/2015-07-02
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/06/nce-exclusivity-challenges-are-hot-hot-hot-ferring-lets-loose-with-the-latest-lawsuit-challenging-de.html
http://www.fiercepharmamanufacturing.com/story/law-enforcement-makes-another-illegal-pharma-supply-chain-bust-2nd-us-8-day/2015-05-26
http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/04/gilead-gild-hiv-aids-taf-tenofovir.html
http://www.fiercepharma.com/story/which-pharma-needs-its-cash-cow-most-its-not-just-about-numbers/2015-03-04
http://www.bloomberg.com/news/articles/2015-02-18/gilead-s-pill-can-stop-hiv-so-why-does-almost-nobody-take-it-
http://www.nytimes.com/2015/02/05/health/failed-trial-in-africa-raises-questions-about-how-to-test-hiv-drugs.html?_r=0
Market Place
Share 
